Misonix Reports Fiscal 2021 Second Quarter Financial Results
February 04, 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
January 21, 2021 10:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 23, 2020 08:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives
December 18, 2020 10:14 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
Misonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 23, 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor Conferences
November 12, 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Fiscal 2021 First Quarter Revenue Rises 59% to $17.7 Million
November 05, 2020 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 First Quarter Financial Results and Host Conference Call and Webcast on November 5
October 20, 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Reports Preliminary Fiscal 2021 First Quarter Revenue of Approximately $17.7 Million
October 06, 2020 07:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix,” the “Company,” “we,” “us” or “our”), a provider of minimally invasive therapeutic ultrasonic medical...
Misonix Enters Into Exclusive Supply and Distribution Agreement With Gunze Limited for TheraGenesis® Bilayer Wound Matrix
September 21, 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue...